Comparison among the Atherogenic Index of Plasma, Ratios of Lipoproteins, Apolipoproteins and Cholesterol Retention Factor (CRF) inPatients with Metabolic Syndrome

Objective: To evaluate various lipid, lipoprotein and apolipoprotein ratios among participants with and without metabolic syndrome. Study Design: Comparative cross-sectional study. Place and Duration of Study: Naval Hospital, Islamabad Pakistan, from Jan 2019 to Dec 2020. Methodology: We selected 16...

Full description

Saved in:
Bibliographic Details
Published inPakistan Armed Forces medical journal Vol. 73; no. 3; pp. 637 - 41
Main Authors Khan, Sikandar Hayat, Afzal, Ahmed Hayat, Gilani, Mehreen, Akhtar, Faisal Naveed, Shahid, Rahat
Format Journal Article
LanguageEnglish
Published Rawalpindi Knowledge Bylanes 30.06.2023
AsiaNet Pakistan (Pvt) Ltd
Army Medical College Rawalpindi
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To evaluate various lipid, lipoprotein and apolipoprotein ratios among participants with and without metabolic syndrome. Study Design: Comparative cross-sectional study. Place and Duration of Study: Naval Hospital, Islamabad Pakistan, from Jan 2019 to Dec 2020. Methodology: We selected 164 patients with metabolic syndrome. Metabolic syndrome was diagnosed as per “NCEP-defined metabolic syndrome criteria”. Insulin resistance was calculated using Homeostasis Model Assessment for Insulin Resistance (HOMA-IR). Various apolipoproteins were calculated using the turbidimetric method on Humastar-200 and lipoproteins by direct detergent methods. Results: The differences for Apo-B/Apo-A1 were found to be higher among metabolic syndrome subjects [{Metabolic syndrome (n=83):0.55±0.22} vs {Non-Metabolic syndrome (n=81):0.50±0.29}, p=0.271]. Area Under Curve (AUC) was highest for the atherogenic index of plasma [0.744], followed by both total cholesterol/HDLc [0.641], Cholesterol Retention Factor (CRF) having [0.641], Apo-B/Apo-A1[0.593] and HDLc/LDLc [0.418]. Conclusion: Differences between subjects with and without NCEP-defined metabolic syndrome were significant for the atherogenic index of plasma (AIP), HDLc/LDLc, and Cholesterol Retention Factor (CRF).
ISSN:0030-9648
2411-8842
DOI:10.51253/pafmj.v73i3.6280